| Literature DB >> 35266601 |
Mitchell L Phillips1, Heather A Ballard1, Nicholas Volpe1, Caroline P Lemoine2, Riccardo A Superina2, Eric C Cheon1.
Abstract
Entities:
Mesh:
Year: 2022 PMID: 35266601 PMCID: PMC9311144 DOI: 10.1111/pan.14432
Source DB: PubMed Journal: Paediatr Anaesth ISSN: 1155-5645 Impact factor: 2.129
Univariable analysis of patients undergoing portosystemic ligation
| Baseline characteristic | Median, IQR/ | OR (95% CI) |
| ||
|---|---|---|---|---|---|
| All patients, | Interstage extubation, | Not extubated, | |||
| Gender, | |||||
| Male | 4 (30.8) | 1 (16.7) | 3 (42.9) | .559 | |
| Female | 9 (69.2) | 5 (83.3) | 4 (57.1) | ||
| Age at surgery, years | 5, 2.8–16 | 16, 4–16 | 2.8, 1.3–12 | .031 | |
| Preoperative lab | |||||
| Hemoglobin | 12.6, 11.7–13.8 | 12.9, 11.7–13.8 | 12.6, 11.2–14.1 | .943 | |
| Platelet | 220, 200–270 | 248, 206–303 | 210, 194–223 | .153 | |
| INR | 1.1, 1.0–1.3 | 1.1, 1.0–1.1 | 1.2, 1.0–1.3 | .234 | |
| Preoperative pressures | |||||
| Nonoccluded shunt pressure | 9, 6–11 | 9, 6–9 | 10, 6–11 | .573 | |
| Occluded shunt pressure | 24, 16–29 | 24, 19–27 | 23.5, 16–29 | .745 | |
| ASA physical status classification, | |||||
| 2 | 3 (23.1) | 2 (33.3) | 1 (14.3) | .559 | |
| 3 | 10 (76.9) | 4 (66.7) | 6 (85.7) | ||
| Weight | 16.0, 12.2–71.6 | 59.8, 16.0–71.6 | 12.2, 10.9–75.8 | .116 | |
| BMI | 18.0, 15.1–22.2 | 20.0, 14.9–23.5 | 16.6, 15.1–22.2 | .668 | |
| History of pulmonary disease | 3 (23.1) | 0 | 3 (42.9) | .192 | |
| Total days scheduled opioid | 14, 7–27 | 6.5, 6–9 | 27, 15–33 | 0.67 (0–0.91) | .002 |
| Total days scheduled benzodiazepine | 9, 0–14 | 0, 0–8 | 14, 9–26 | 0.60 (0.08–0.95) | .008 |
| Adjuvants | |||||
| Ketamine | 4 (30.8) | 2 (33.3) | 2 (28.6) | 1.25 (0.12–13.24) | .853 |
| Clonidine | 4 (30.8) | 1 (16.7) | 3 (42.9) | 0.27 (0.019–3.65) | .322 |
| Dexmedetomidine | 9 (69.2) | 3 (50.0) | 6 (85.7) | 0.17 (0.01–2.36) | .186 |
| Discharged on methadone | 5 (38.4) | 0 | 5 (71.4) | 0.82 (0–0.83) | .03 |
| Total length of mechanical ventilation, days | 8, 1–11 | 1, 0–2 | 11, 9–17 | 0.64 (0–0.88) | .002 |
| Cardiac arrest | 1 (7.7) | 0 | 1 (14.3) | 1.17 (0–45.5) | .355 |
| Total ICU stay, days | 10, 8–20 | 8, 6–9 | 20, 13–20 | 0.52 (0–0.88) | .002 |
| Total hospital stay, days | 19, 14–28 | 13.5, 11–14 | 28, 19–33 | 0.59 (0.20–0.93) | .005 |
Abbreviations: ASA, American Society of Anesthesiologists; BMI, body mass index; CI, confidence interval; ICU, intensive care unit; INR, international normalized ratio; IQR, interquartile range; OR, odds ratio.
| Congenital cardiovascular disease |
| Moderate to severe pulmonary hypertension |
| Age <1 (relative contraindication) |
| Significant blood loss (>25 ml/kg) |
| Vasopressor requirement |
| Dexmedetomidine |
| Ketamine |
| Midazolam |
| Hydromorphone |
| Fentanyl |
| Morphine |